Imugene’s azer-cel trial sees tumours temporarily disappear in 3 of 10 patients
Imugene (ASX:IMU) has announced 3 patients in its latest blood cancer treatment…
Fri, 18 Oct | Last | Change |
1:01pm | 8,294.3 | 61.6 |
Currently Trading at Fri, 18 Oct 1:03pm |
S&P/ASX Sm. Ords. | 3,196.5 | 32.6 | 1.01% |
All Ordinaries | 8,563.8 | 60.3 | 0.70% |
S&P/ASX 100 | 6,967.1 | 50.0 | 0.71% |
OVT | OVANTI LIMITED | 2.5¢ | 78.6% |
IRX | INHALERX LIMITED | 3.9¢ | 77.3% |
LGP | LITTLE GREEN PHARMA LTD | 15.0¢ | 30.4% |
MOV | MOVE LOGISTICS GROUP LIMITED | 21.0¢ | 36.4% |
PER | PERCHERON THERAPEUTICS LIMITED | 8.9¢ | 34.1% |
LVH | LIVEHIRE LIMITED | 3.2¢ | 20.0% |